Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure choices remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline We https://financefeeds.com/ai-investment-opportunities-caro-holdings-otc-caho-poised-for-growth/